FRAGMENT is a biotechnology and consumer product development company specializing in high-intensity industrial scale ultrasonic technology to create commercial use nanoemulsions and nanocrystals.
FRAGMENT’s focus is developing and distributing “water soluble” cannabinoid consumer products suitable for beverage, cosmetic, food, and pharmaceutical applications, both privately and white-label.
FRAGMENT represents the next generation of cannabinoid processing.
FRAGMENT uses patented industrial scale expandable ultrasonic processors with standard SOP’s and GRAS (natural) ingredients with a goal of becoming cGMP.
Company Details
- Founded
- -
- Address
- La Jolla, Ca 92037, Us
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Keywords
- Cannabinoid nanoemulsification, Nanotization, Nanoemulsion, Key Performance Indicators, Branding, Product Development, Marketing, Distribution, Project Management, Distillation, Creativity, Compliance, Laboratory, Policies & Procedures, Chemistry, Science, Finance, Human Resources, Team Building, Mergers & Acqusitions.
- HQ
- La Jolla, CA
Fragment Pharma, Inc. Questions
Fragment Pharma, Inc.'s LinkedIn profile is https://www.linkedin.com/company/fragment-pharma-inc
Fragment Pharma, Inc.'s industry is
Nanotechnology Research
Fragment Pharma, Inc.'s top competitors are
Marketmapr,
Resurrection Financial,
360 One Firm (361firm),
Invictus Advisors Llc,
Invictus Impact Capital Partners Llc.
Fragment Pharma, Inc.'s categories are Nanotechnology Research
Fragment Pharma, Inc.'s founding year is 2019
